Wolverine Asset Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,653
Closed -$16.4K 1685
2023
Q4
$16.4K Sell
4,653
-3,000
-39% -$8.61K ﹤0.01% 1342
2023
Q3
$19.8K Sell
7,653
-1,355
-15% -$4.76K ﹤0.01% 1362
2023
Q2
$35.5K Sell
9,008
-936
-9% -$2.97K ﹤0.01% 1213
2023
Q1
$33.6K Buy
9,944
+1,510
+18% +$6.16K ﹤0.01% 1265
2022
Q4
$30.2K Sell
8,434
-2,000
-19% -$8.55K ﹤0.01% 1460
2022
Q3
$42K Buy
10,434
+888
+9% +$4.56K ﹤0.01% 1636
2022
Q2
$42K Buy
9,546
+206
+2% +$1.49K ﹤0.01% 1612
2022
Q1
$79K Buy
9,340
+1,143
+14% +$8.03K ﹤0.01% 1376
2021
Q4
$72K Buy
8,197
+587
+8% +$5.58K ﹤0.01% 1442
2021
Q3
$79K Buy
7,610
+4,259
+127% +$37.2K ﹤0.01% 1338
2021
Q2
$35K Buy
3,351
+2,851
+570% +$28.1K ﹤0.01% 1765
2021
Q1
$5K Sell
500
-94,923
-99% -$1.32M ﹤0.01% 1924
2020
Q4
$1.06M Sell
95,423
-176,780
-65% -$1.8M 0.01% 634
2020
Q3
$2.73M Buy
272,203
+171,203
+170% +$1.73M 0.02% 342
2020
Q2
$1.01M Buy
+101,000
New +$992K 0.01% 545

Other funds holding SRTA

Wolverine Asset Management's SRTA Position: Q1 2024 in Review

Wolverine Asset Management sold out of Strata Critical Medical Inc (SRTA) in Q1 2024, closing a stake of 4,653 shares — an estimated $16.4K sold.

Wolverine Asset Management first reported a position in SRTA in Q2 2020 and held it in 15 quarters. The position peaked at $2.73M in Q3 2020. 114 funds tracked by Wall St. Rank hold SRTA as of Q1 2024.

  • Wolverine Asset Management reported no remaining Strata Critical Medical Inc position as of Q1 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 4,653 Strata Critical Medical Inc shares in Q1 2024, an estimated $16.4K.
  • Wolverine Asset Management first reported a position in Strata Critical Medical Inc in Q2 2020 and held it in 15 quarters.
  • Wolverine Asset Management's Strata Critical Medical Inc position peaked at $2.73M in Q3 2020.
  • 114 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2024.

Based on Wolverine Asset Management's 13F filing for Q1 2024, filed 13 May 2024.